BREAKTHROUGHS BY PHYSICIANS FOR PHYSICIANS
Imbio works with the most trusted names in healthcare to bring breakthrough image analysis to daily clinical care. Functional Lung Density Analysis™ is based on the patented PRM (Parametric Response Mapping) technology pioneered at the University of Michigan.
While recognized as today’s standard of diagnosis, pulmonary function tests (PFT’s) alone can be inconclusive. As many as 1/3 of individuals with respiratory symptoms may have normal PFT’s.3 Imbio LDATM utilizing PRM provides visualization and quantification of the components of COPD not available through PFT’s, supporting more personalized diagnosis, therapy tracking and surgical or interventional procedure planning.
1. World Health Organization. Accessed online Feb 1, 2017. http://www.who.int/respiratory/copd/en/
2. Wang et al. Optimal threshold in CT quantification of emphysema. Eur Radiol. 2013 Apr;23(4):975-84.
3. Regan E, et al. Clinical and Radiologic Disease in Smokers with Normal Spirometry. JAMA Intern Med. 2015. Doi:10.1001/jamainternmed.2015.2735.